Monthly Archives: December 2010

EMA Draft Guidelines For Biosimilar Antibodies Released

From Dr. Stefan Danner On November 18, 2010, the European Medicines Agency (EMA) released draft versions of two guidelines relating to the regulatory approval of monoclonal antibodies: the “Guideline on biological medicinal products containing monoclonal antibodies”1 and the “Guideline on … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , | Leave a comment

A European view of RCT v. Microsoft – A Pyrrhic victory?

From Paul Cole The law gets into a mess when a court does the right things for the wrong reasons. By way of introduction, the present proceedings concern a method for the production of halftone images created at the University … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , | Leave a comment

RCT v. Microsoft – Fed. Cir. “Accepts” Bilski Invitation

On December 8, 2010, the Fed. Cir. (Rader writing) reversed the district court’s holding that claims to a process for rendering a half-tone image of a digital image were patent ineligible as an attempt to claim an abstract idea. Research Corp. … Continue reading

Posted in Patentable Subject Matter, Written Description Requirements (WDR) | Tagged , , , , , , , , , | Leave a comment

Prometheus V. Mayo – Fed. Cir: “We Got It Right The First Time.”

Today, following the vacation and remand of its earlier decision by the Supreme Court post-Bilski, the Federal Circuit again reaffirmed its reversal of the District Court (copy at the end of this post) and held: “The asserted method claims satisfy … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , | Leave a comment